查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1599255

獸醫分子診斷市場：按產品類型、技術、動物類型、適應症和最終用戶 - 2025-2030 年全球預測

Veterinary Molecular Diagnostic Market by Product (Instruments & Software, Kits & Reagent, Services), Technology (DNA Sequencing, Microarrays, Polymerase Chain Reaction), Animal Type, Disease Indication, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年獸醫分子診斷市值為5.7974億美元，預計到2024年將達到6.324億美元，複合年成長率為9.17%，預計到2030年將達到10.7185億美元。

動物分子診斷市場專注於先進的診斷技術，如 PCR、微陣列和次世代定序(NGS)，以高精度識別動物的病原體、遺傳疾病和其他分子層面的健康問題。對此類診斷的需求源於通用感染疾病的日益流行、動物健康意識的提高以及加強食品安全的需要。應用範圍涵蓋伴同性動物、牲畜和研究牲畜管理，為獸醫、診斷實驗室和研究機構提供服務。推動成長的主要因素包括技術進步、寵物擁有增加、獸醫保健投資以及動物疾病發生率上升。值得注意的是，人工智慧和機器學習在診斷領域的日益融合，加上對微創手術的需求，正在創造巨大的商機。公司可以透過投資自動化、提高測試靈敏度以及擴大測試範圍以涵蓋新出現的病原體來利用這些機會。然而，市場面臨分子診斷成本高、新興市場地區獸醫基礎設施有限以及監管障礙等挑戰，這些可能會阻礙成長。該行業可以從專注於經濟高效技術、攜帶式診斷設備和全面基因組測試的創新中受益。還可以研究可以同時檢測多種病原體的多重檢測。該市場競爭激烈，且分散，既有現有企業，也新興企業，需要專注於策略夥伴關係和聯盟，以擴大地理影響力和產品供應。雲端基礎的動物診斷資料分析的創新為個人化動物照護服務提供了動力。對獸醫進行分子診斷教育和培訓的策略重點對於招募至關重要。為了實現成長，我們必須解決定價問題，擴大基礎設施，提高開拓市場中診斷服務的可近性，並確保這些創新診斷解決方案的採用和影響。

主要市場統計
基準年[2023] 57974萬美元
預測年份 [2024] 6.324 億美元
預測年份 [2030] 1,071,850,000 美元
複合年成長率（%） 9.17%

市場動態：快速發展的獸醫分子診斷市場的關鍵市場洞察

供需的動態交互作用正在改變獸醫分子診斷市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 飼養的伴同性動物和牲畜數量增加
    • 改善經濟國家的獸醫設施
    • 動物慢性疾病增加
  • 市場限制因素
    • 與先進的分子診斷設備和檢測相關的高成本
  • 市場機會
    • 動物分子診斷技術進展
    • 寵物保險普及
  • 市場挑戰
    • 缺乏熟練的專業人員

波特五力：駕馭獸醫分子診斷市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解獸醫分子診斷市場的外部影響

外部宏觀環境因素在塑造獸醫分子診斷市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解動物分子診斷市場的競爭狀況

對獸醫分子診斷市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣獸醫分子診斷市場供應商績效評估

FPNV定位矩陣是評估獸醫分子診斷市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃獸醫分子診斷市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對動物分子診斷市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 飼養寵物和牲畜的數量增加
      • 改善經濟中的獸醫護理設施
      • 動物慢性病發生率增加
    • 抑制因素
      • 與先進的分子診斷設備和測試相關的高成本
    • 機會
      • 動物分子診斷技術進展
      • 擴大寵物保險的保障範圍
    • 任務
      • 缺乏熟練的專業人員
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章動物分子診斷市場：依產品

  • 設備和軟體
  • 試劑套件和試劑
  • 服務

第7章動物分子診斷市場：依技術分類

  • DNA序列分析
  • 微陣列
  • 聚合酵素鏈鎖反應

第8章按動物類型分類的動物分子診斷市場

  • 寵物
    • 狗
    • 馬
    • 貓科動物
  • 家畜
    • 牛
    • 綿羊或山羊
    • 豬肉
    • 家禽

第9章獸醫分子診斷市場：依疾病適應症

  • 腹瀉病原體檢測
  • 呼吸道病原體檢測
  • 性行為感染的感染

第10章獸醫分子診斷市場：依最終用戶分類

  • 醫院
  • 參考實驗室
  • 獸醫診所

第11章美洲動物分子診斷市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太獸醫分子診斷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲獸醫分子診斷市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Biochek BV
  • Biomedica Medizinprodukte GmbH
  • BioMerieux SA
  • Bioneer Corp
  • HealthGene Corporation
  • Heska Corporation
  • IDEXX Laboratories, Inc.
  • Novacyt Group
  • Quality Vet Lab
  • Randox Laboratories, Ltd.
  • Thermo Fisher Scientific, Inc.
  • VCA, Inc.
  • Veterinary Molecular Diagnostics Inc.
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-034B50030397

The Veterinary Molecular Diagnostic Market was valued at USD 579.74 million in 2023, expected to reach USD 632.40 million in 2024, and is projected to grow at a CAGR of 9.17%, to USD 1,071.85 million by 2030.

The veterinary molecular diagnostic market focuses on advanced diagnostic techniques like PCR, microarrays, and next-generation sequencing (NGS) to identify pathogens, genetic disorders, and other molecular-level health issues in animals with high accuracy. The necessity for such diagnostics arises from the increased prevalence of zoonotic diseases, growing awareness toward animal health, and the need for enhanced food safety. Applications span across companion animals, livestock, and research livestock management, serving veterinarians, diagnostic labs, and research institutes. Key factors driving growth include technological advancements, increased pet ownership, investments in veterinary healthcare, and the rising incidence of animal diseases. Notably, the growing integration of AI and machine learning in diagnostics, combined with the demand for minimally invasive procedures, creates significant opportunities. Companies can capitalize on these opportunities by investing in automation, enhancing test sensitivity, and broadening their test offerings to include novel and emerging pathogens. However, the market faces challenges such as high costs of molecular diagnostics, limited veterinary infrastructure in developing regions, and regulatory hurdles, which can impede growth. The field can benefit from innovations focused on cost-effective technologies, portable diagnostic devices, and comprehensive genomic testing. Research might explore multiplex assays capable of simultaneous testing for multiple pathogens. The market is competitive and fragmented with a mix of established firms and startups, necessitating a focus on strategic partnerships and collaborations to expand geographical presence and product offerings. Innovation in cloud-based data analytics for veterinary diagnostics will enhance personalized animal care services. Strategic focus on education and training for veterinarians on molecular diagnostics is crucial for adoption. Achieving growth requires addressing pricing issues, scaling up infrastructure, and increasing accessibility to diagnostic services in untapped markets, ensuring a wider reach and impact of these innovative diagnostic solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 579.74 million
Estimated Year [2024] USD 632.40 million
Forecast Year [2030] USD 1,071.85 million
CAGR (%) 9.17%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary Molecular Diagnostic Market

The Veterinary Molecular Diagnostic Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing number of companion animal and livestock ownership
    • Improving veterinary care facilities in economies
    • Rising incidence of chronic diseases in animals
  • Market Restraints
    • High cost associated with sophisticated molecular diagnostics instruments and assays
  • Market Opportunities
    • Advances in veterinary molecular diagnostic technology
    • Growing availability of pet insurance
  • Market Challenges
    • Lack of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary Molecular Diagnostic Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary Molecular Diagnostic Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary Molecular Diagnostic Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary Molecular Diagnostic Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary Molecular Diagnostic Market

A detailed market share analysis in the Veterinary Molecular Diagnostic Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary Molecular Diagnostic Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary Molecular Diagnostic Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary Molecular Diagnostic Market

A strategic analysis of the Veterinary Molecular Diagnostic Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Molecular Diagnostic Market, highlighting leading vendors and their innovative profiles. These include Biochek BV, Biomedica Medizinprodukte GmbH, BioMerieux SA, Bioneer Corp, HealthGene Corporation, Heska Corporation, IDEXX Laboratories, Inc., Novacyt Group, Quality Vet Lab, Randox Laboratories, Ltd., Thermo Fisher Scientific, Inc., VCA, Inc., Veterinary Molecular Diagnostics Inc., Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Molecular Diagnostic Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Instruments & Software, Kits & Reagent, and Services.
  • Based on Technology, market is studied across DNA Sequencing, Microarrays, and Polymerase Chain Reaction.
  • Based on Animal Type, market is studied across Companion Animal and Livestock Animal. The Companion Animal is further studied across Canine, Equine, and Feline. The Livestock Animal is further studied across Bovine, Ovine or Caprine, Porcine, and Poultry.
  • Based on Disease Indication, market is studied across Diarrhea Pathogens Detection, Respiratory Pathogens Detection, and Vector Borne Diseases.
  • Based on End User, market is studied across Hospitals, Reference Laboratories, and Veternary Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of companion animal and livestock ownership
      • 5.1.1.2. Improving veterinary care facilities in economies
      • 5.1.1.3. Rising incidence of chronic diseases in animals
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with sophisticated molecular diagnostics instruments and assays
    • 5.1.3. Opportunities
      • 5.1.3.1. Advances in veterinary molecular diagnostic technology
      • 5.1.3.2. Growing availability of pet insurance
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Veterinary Molecular Diagnostic Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments & Software
  • 6.3. Kits & Reagent
  • 6.4. Services

7. Veterinary Molecular Diagnostic Market, by Technology

  • 7.1. Introduction
  • 7.2. DNA Sequencing
  • 7.3. Microarrays
  • 7.4. Polymerase Chain Reaction

8. Veterinary Molecular Diagnostic Market, by Animal Type

  • 8.1. Introduction
  • 8.2. Companion Animal
    • 8.2.1. Canine
    • 8.2.2. Equine
    • 8.2.3. Feline
  • 8.3. Livestock Animal
    • 8.3.1. Bovine
    • 8.3.2. Ovine or Caprine
    • 8.3.3. Porcine
    • 8.3.4. Poultry

9. Veterinary Molecular Diagnostic Market, by Disease Indication

  • 9.1. Introduction
  • 9.2. Diarrhea Pathogens Detection
  • 9.3. Respiratory Pathogens Detection
  • 9.4. Vector Borne Diseases

10. Veterinary Molecular Diagnostic Market, by End User

  • 10.1. Introduction
  • 10.2. Hospitals
  • 10.3. Reference Laboratories
  • 10.4. Veternary Clinics

11. Americas Veterinary Molecular Diagnostic Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Veterinary Molecular Diagnostic Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Veterinary Molecular Diagnostic Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Biochek BV
  • 2. Biomedica Medizinprodukte GmbH
  • 3. BioMerieux SA
  • 4. Bioneer Corp
  • 5. HealthGene Corporation
  • 6. Heska Corporation
  • 7. IDEXX Laboratories, Inc.
  • 8. Novacyt Group
  • 9. Quality Vet Lab
  • 10. Randox Laboratories, Ltd.
  • 11. Thermo Fisher Scientific, Inc.
  • 12. VCA, Inc.
  • 13. Veterinary Molecular Diagnostics Inc.
  • 14. Virbac S.A.
  • 15. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. VETERINARY MOLECULAR DIAGNOSTIC MARKET RESEARCH PROCESS
  • FIGURE 2. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. VETERINARY MOLECULAR DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. VETERINARY MOLECULAR DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VETERINARY MOLECULAR DIAGNOSTIC MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VETERINARY MOLECULAR DIAGNOSTIC MARKET DYNAMICS
  • TABLE 7. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS & SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY KITS & REAGENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CANINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY EQUINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY FELINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY BOVINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY OVINE OR CAPRINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PORCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DIARRHEA PATHOGENS DETECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY RESPIRATORY PATHOGENS DETECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY VECTOR BORNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY VETERNARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY VETERINARY MOLEC